Mary Ellen Hackett
Manager, Communications Office
Email maryellen.hackett@nih.gov or call 301-401-8670 for all media related questions.
Analysis of paired blood biopsies, tumor tissue as biomarkers for cancer to be presented at ASCO
FNL scientists will present a recent study comparing mutations found in paired tuors and ctDNA at the 2026 American Society for Clinical Oncology Annual Meeting.POSTED: 5/29/2026
New tools may better predict breast cancer in women of African descent
researchers developed new polygenic risk factor models built around four especially aggressive breast cancer phenotypes.POSTED: 5/19/2026
Researchers identify lower GI tract tissues as source of initial rebound of HIV-like virus after stopping ART
A new study used an innovative method to track anatomic origin of rebound of HIV-like virus.POSTED: 5/13/2026
Seeing pancreatic cancer one cell at a time
Single-cell analysis reveals PDAC evolution is more complex than “KRAS-driven”—with diverse clones, variable dependence, and alternative pathways shaping tumors.POSTED: 5/11/2026
Upcoming Life Sciences Symposium will grapple with reproducibility crisis
Experts across scientific fields will convene June 16–18 for a symposium aiming to ameliorate the so-called “reproducibility crisis” in research.POSTED: 4/27/2026
NIH partnership establishes new Gene Therapy Immunology and Standards Laboratory
A new initiative aims to standardize gene therapy research, speeding the path to clinical trials and new treatments.POSTED: 4/23/2026
Preclinical data on potential treatment for RAS-driven cancers to be presented at AACR26
Studies on BBO-10203 and BBO-11818 will be presented in San Diego.POSTED: 4/16/2026
Vertical RAS Pathway Inhibition Creates a Ferroptosis-Prone State in Pancreatic Cancer
KRAS pathway inhibition rewires PDAC metabolism, increasing oxidative stress—and revealing a new vulnerability: ferroptosis as a strategy to overcome resistance.POSTED: 4/13/2026
Vaccine set for wider use against mosquito-borne chikungunya
The vaccine Vimkunya may become a bigger player in global health following a series of adverse event reports linked to the only other available vaccine for chikungunya.POSTED: 3/25/2026
Research team identifies possible new targets for liver cancer therapy
New research may have found a stable population of cells that could serve as a bull's eye for effective liver cancer therapy.POSTED: 3/19/2026
Looking for more?
Explore our scientific publications
Our researchers publish hundreds of papers each year in various peer-reviewed journals, including Science, Nature, and The New England Journal of Medicine.